We purified the neuraminidase (sialidase, acylneut-aminyl hydrolase, EC 3.2
against the denatured protein recognized the qeuraminidase in membrane extracts from the infectious stage but not from the noninfectious stage. Sera from a patient with acute chagasic disease also reacted strongly with the neuraminidase. Other T. cruzi strains exhibited similar neuraminidase activities and induction rates. The coincidence of infectivity and enhanced expression of neuraminidase in trypomastigotes suggests that this enzyme constitutes a virulence factor in T. cruzi.
Neuraminidase (sialidase, acylneuraminyl hydrolase, EC 3.2.1.18) cleaves terminal sialic acid residues from glycoproteins, glycolipids, and oligosaccharides (1) . This enzyme, the production of which is often inducible, has been found in a number of microorganisms and animal tissues (2) , including Trypanosoma cruzi (3) .
This protozoan parasite causes Chagas disease, which affects some twenty million people throughout Central and South America (4) . The parasite undergoes a number of morphologic and physiologic changes as it passes between two hosts, a reduviid bug and man. The epimastigote residing in the midgut of the insect and the amastigote in the mammalian cell cytoplasm are the replicative forms of the parasite. Neither form is capable of actively invading a host cell. The trypomastigote serves as the infectious vehicle and does not replicate. This form occurs as metacyclic trypomastigote and blood-form trypomastigote. The metacyclic trypomastigote, residing in the hindgut of the insect, is spread via the feces of infected reduviid bugs in the course of an infection. In contrast, the blood-form trypomastigote is derived from the amastigote in infected individuals. Despite some physiologic and biochemical differences, both trypomastigote forms exhibit highly increased neuraminidase activity compared to the other two forms (3) . Therefore, this enzyme is developmentally regulated in T. cruzi. With the exception of influenza virus, the biological function of neuraminidase isolated from microorganisms still remains unclear (2) . However, the coincidence of infectivity and enhanced expression of neuraminidase in trypomastigotes suggests that this enzyme constitutes a virulence factor in T.
cruzi.
We describe properties of this protein and demonstrate its developmental regulation by activity assays and tthe use of monospecific, polyclonal antineuraminidase antibodies. For comparison, Trypanosoma rangeli (5) and Leishmania major (6) , two other protozoan parasites that are. taxonomically related to T. cruzi, are included in these studies.
MATERIALS AND METHODS
Parasite Strains. Trypanosoma cruzi strain Y, zymodeme 2 (7) , was obtained from M. Pereira (Department ofGeographic Medicine, Tufts University, Boston). S. Nickell from our department provided T. cruzi strains Brazil, clone C15C2, not typed (8) , and Silvio X10/4, zymodeme 1 (9). L. major WR 567 (6) also was from S. Nickell. T. cruzi Tulahuen, zymodeme 3 (7), and T. rangeli d'Alessandro (5) were gifts from R. Kuhn (Department of Biology, Wake Forest University, Winston-Salem, NC).
Cell Cultures. Epimastigotes of all the T. cruzi strains were grown at 270C in brain heart infusion medium, pH 7.4, supplemented with 10% fetal bovine serum (cBHIL, Difco). T. rangeli d'Alessandro epimastigotes and promastigotes and promastigotes of L. major WR 567 were maintained in the same medium. Harvested parasites (all forms) were stored frozen at -70'C at a density of 1 x 109 cells/ml in storage buffer [25 Metacyclic trypomastigotes of the various T. cruzi strains were obtained by culturing epimastigotes for 7 days at 270C in Grace's insect tissue culture medium (Grace's, GIBCO) (10) . Metacyclics were separated from epimastigotes by two cycles of metrizamide gradient centrifugation (Nyegaard, Oslo) (11) followed by chromatography on DEEAE (Whatman) (12) . Typically, 50% of the parasites converted to metacyclic trypomastigotes. After purification, the separated organisms were 90-95% homogeneous. The metacyclic trypomastigotes were characterized by the apical location of the kinetoplast (4), their capability to infect Vero cells (American Type Culture Collection CCL 81, obtained from E. Chen, Scripps Clinic, La Jolla, CA), and their resistance to lysis by guinea pig complement (GIBCO) (13) . T. rangeli and L. major were also grown in Grace's medium to test for morphologic changes and induction of neuraminidase activity. Morphol Purification of the Neuraminidase to Apparent Homogeneity. All operations were done at 4°C. Enzyme-containing solutions included all the protease inhibitors as specified for storage buffer. The enzyme was purified from soluble membrane proteins of 4 x 1010 T. cruzi Y parasites containing 3.2 x 1010 metacyclic trypomastigotes and 0.8 x 1010 epimastigotes. First, the soluble membrane proteins were applied to a 100-ml Affi-Gel Blue column (100-200 mesh; Bio-Rad).
Neuraminidase was eluted from the column at 350-400 mM NaCI. Next, the enzyme was applied to a 100-ml DEAE DE-52 column and eluted at 250-300 mM NaCl. The active fractions were then chromatographed on 5-ml N-(p-aminophenyl)oxamic acid-agarose (Sigma), eluted at 300-400 mM NaCl, and applied to 10-ml wheat germ lectin-Sepharose 6MB. The protein was eluted with buffer A plus 250 mM NaCl and 250 mM N-acetyl-D-glucosamine. The active fractions were immediately size fractionated through Bio-Gel P-150 (1502240; 100-200 mesh; Bio-Rad). At that stage, the enzyme was apparently homogeneous, as judged by silver staining of an aliquot run on a denaturing polyacrylamide gel. The active enzyme was stored at 4°C in buffer A plus 250 mM NaCI. Most purified protein was electroeluted twice from denaturing polyacrylamide gels and acetone extracted (i4, 15). The yield was about 75 ,g of neuramiinidase, or 40% ofthe starting material. No enzymatic activity was detected after these extractions.
Enzyme Assays. Standard assays were run in 100 mM sodium acetate, pH 6.8, for 20 hr at 37°C with 390 nmol of bound sialic acids in 2'-(4-methylumbelliferyl)-a-D-N-acetylneurarninic acid (4MU-NANA; Sigma). All quantitative assays contained 660 nmol of bound sialic acids in the various substrates (16) , and the enzyme units equivalent to 2.5 x 107 organisms ( Table 2 ). The release of NANA from 4MU-NANA was determined fluorometrically (17) from the other substrates by the alkali-Ehrlich method (18) . One unit of enzyme is defined as the amount needed to release one ,umol of N-acetylneuraminic acid from N-acetylneuraminyl lactose in 1 min at 37°C (19) . We used 4MU-NANA as the reference substrate.
Gel Electrophoresis. Denaturing gels were Laemmli systems (20) . Proteins were stained with silver nitrate (Sigma) (21) . Mr markers were from Pharmacia and Sigma. Mr values are given as Mr X i0-3 in the figures. Enzyme activity and protein concentration were determined according to standard procedures (17, 24) . N-(p-A)OX-A, N-(p-aminophenyl)oxamic acid-agarose; WGA-Seph., wheat germ lectin-Sepharose 6MB.
Generation of Antibodies. Antisera were produced in 4-moold female New Zealand White rabbits. Each of two rabbits, 2963 and 2964, that showed no reactivity against T. cruzi antigens received s.c. injections of 10 gg of purified and extracted neuraminidase in complete Freund's adjuvant (Difco) and 10 days later a second injection of 15 gg of neuraminidase in incomplete Freund's adjuvant (Difco).
Immunoglobulins were prepared from postimmune sera taken 10 and 30 days after the second injection, as well as from preimmune sera by chromatography on protein A-Sepharose CL-4B (Pharmacia).
Patient Sera. The patient sera used in immunoblots were from a well-documented case of acute Chagas disease in California (22) . Sera were obtained from the Centers for Disease Control (Atlanta, GA). As measured by complement fixation at the Centers for Disease Control, titer in the acute phase serum was 1:512; 2 weeks later it was 1:256; 4 weeks later it was 1:32; and 8 mo after infection serum titer was 1:4. These sera were used in a 1:250 dilution. 
RESULTS

Purification of T. cruzi Y Neuraminidase and Analysis of Its
Differential Expression. We isolated the neuraminidase from cell membranes of metacyclic trypomastigotes grown under axenic conditions. The enzyme was purified more than 5000-fold to apparent homogeneity by several chromatography steps and size fractionation (Table 1) . It migrated as a single band of Mr 60,000 in a silver-stained denaturing polyacrylamide gel (Fig. 1) . When isolated from tissue culture trypomastigotes and culture supernatants, the enzyme also migrated as a Mr 60,000 entity (data not shown).
Quantitation of Neuraminidase Activity in T. cruzi Y. Using various substrates, quantitative assays were done on partially purified membrane extracts of epimastigotes, metacyclic and tissue culture trypomastigotes, and amastigotes. As summarized in Table 2 , the neuraminidase activity increased 17-fold in metacyclics compared to epimastigotes. Tissue culture trypomastigotes possessed slightly more neuraminidase than did metacyclic trypomastigotes, whereas amastigotes were found to be almost devoid of the enzyme. The extremely small amount ofdetectable enzyme activity ofthe latter could easily be accounted for by contamination with tissue culture trypomastigotes.
The neuraminidase was active on a variety of biological substrates containing differently linked and modified sialic acid residues (16 To analyze the specificity of the immunoglobulin in more detail, immunologic blots were done with partially purified membrane extracts from four T. cruzi strains and also from T. rangeli d'Alessandro and L. major WR 567. These results were compared with reactions ofthe purified enzyme (Fig. 2) . The band that reacted most strongly with the antineuraminidase antibodies 2963 in all extracts from metacyclics of various T. cruzi strains was a protein with an -Mr of 60,000. This strong band correlated well with the purified enzyme. Several other protein species reacted weakly with the antibodies. Ig 2964 reacted less specifically with the neuraminidase than did Ig 2963 (data not shown). At the dilution used (1:500), the antibodies did not detect the enzyme in epimastigotes. Only antibody dilutions as low as 1:50 and 1:100 allowed detection of several bands in membrane extracts from epimastigotes-the strongest one being in the range of Mr 60,000 (data not shown). This evidence suggested that the enzyme was an Mr 60,000 entity in epimastigotes as well. Preimmune globulins did not recognize proteins in either extract.
The immunoglobulins recognized the same two bands in T. rangeli extracts, independent of the growth conditions. One protein was of Mr 180,000-200,000, and the other one was a broad band at about Mr 48,000-50,000. It is not known whether these two proteins are related or whether either is responsible for the small amount of neuraminidase activity detected in this parasite ( Table 3 ). The antibodies did not detect any proteins in L. major, even when diluted 1:250 and 1:100 in subsequent blots (data not shown).
Reaction of Parasite Membrane Antigens with Chagasic
Sera. Because metacyclic trypomastigotes that are spread via Enzyme units detected were standardized to 2.5 x 10' cells of the various parasites. 4MU-NANA was used as the substrate. NA, neuraminidase; B, Brazil C15C2; S, Silvio X10/4; T, Tulahuen; Epi, epimastigotes; MT, metacyclic trypomastigotes; P. promastigotes. BHI, cBHIL, and GR, Grace's, growth media. The values given represent the mean of five experiments; maximum SD was ± 10%o. the feces of infected reduviid bugs in the course of an infection (4) express high levels of neuraminidase, sera from patients with Chagas disease could contain antibodies directed against this molecule. The sera used in this study were from an acute chagasic patient who contracted the infection in August 1982 (22) .
We probed partially purified membrane proteins from metacyclics of strain Y, zymodeme 2 (7) and Tulahuen, zymodeme 3 (7) with sera from this patient. Because T. rangeli (5), which is nonpathogenic to man, and L. major (6), the causative agent of human cutaneous leishmaniasis, are taxonomically related to T. cruzi, we probed partially purified membrane proteins from cBHIL/Grace's cultures of these two parasites with the same sera (Fig. 3) . In general, sera taken at different times during the infection recognized the same set of antigens in strain Y. One protein that reacted strongly with these sera migrated as an Mr 60,000 entity. Dot blot analyses using the chagasic sera to probe the purified homogeneous neuraminidase from T. cruzi Y revealed a strong reaction as well (data not shown). Thus, the Mr 60,000 band was most likely the neuraminidase, which was apparently expressed in vivo in quantities sufficient to induce a strong antibody response. Intensity of the neuraminidase signal decreased gradually, and 8 mo after infection the enzyme could no longer be detected by the individual's sera. The antigens that were detected in T. cruzi Tulahuen matched those in T. cruzi Y quite well. As with T. cruzi Y, the neuraminidase was one of the predominant antigens. Furthermore, the intensity of the neuraminidase band gradually faded over the 8-mo period, after which antigens could no longer be detected.
In contrast, the pattern observed in T. rangeli d'Alessandro not only differed over time but also markedly from the two T. cruzi strains. Although the sera taken 2 weeks after infection recognized a protein in the range of Mr 60,000, we think that the protein does not correlate with the neuraminidase in this parasite because no corresponding band could be detected when the same extracts were probed with monospecific antineuraminidase antibodies (Fig. 2) . No antigens were recognized by the antibodies in partially purified membrane extracts from L. major WR 567.
DISCUSSION
The neuraminidase of the unicellular parasite T. cruzi is a developmentally regulated enzyme. Expression of this protein, as measured by enzyme activity, is greatly increased in the infectious trypomastigote form compared to the other forms of the parasite. This developmental regulation is seen not only in strain Y, from which the neuraminidase was initially purified, but also in several other T. cruzi strains. On the average, metacyclic trypomastigotes of all the T. cruzi strains examined contained ten times more enzyme activity than did epimastigotes.
The neuraminidase was of parasitic origin because it was purified from plasma membrane proteins of metacyclic trypomastigotes grown under axenic conditions. Independent of the enzyme source, the activity always copurified with a protein of Mr 60,000. The neuraminidase was active on a variety of substrates containing differently linked sialic acids. At present, we do not know the in vivo substrate for T. cruzi neuraminidase. The neuraminidase probably is associated with the parasite's plasma membrane because the cellular subfraction that contained detergent-solubilized membrane proteins possessed 80-90% of the neuraminidase activity. All other fractions contained <10% of the total activity (data not shown).
Data from the immunologic blots with chagasic sera showed that the neuraminidase in T. cruzi strains Y, zymodeme 2 (7) and Tulahuen, zymodeme 3 (7), was one antigen that reacted strongly with acute-phase sera from a patient infected with a zymodeme 1 T. cruzi strain (22) . Our findings suggest strongly that the enzyme is expressed by parasites of all three zymodemes during naturally occurring infections. Furthermore, antisera produced in rabbits against purified neuraminidase from strain Y, zymodeme 2, also detected the enzyme in metacyclic trypomastigotes from T. cruzi Silvio X10/4, zymodeme 1 (9), Tulahuen, zymodeme 3 (7), and Brazil, clone C15C2, not typed (8) . Hence, a considerable amount of antigenic similarity exists among neuraminidases from these different strains. The two taxonomically related parasites T. rangeli d'Alessandro and L. major WR 567 exhibited only little neuraminidase activity that was not inducible by culture in Grace's medium. However, the enzyme in these two parasites could have different assay requirements, or its activity could be regulated during the cell cycle in a way not detected with methods used for the other parasites.
It is unclear what triggers enhanced expression of the neuraminidase in trypomastigotes cultured in vitro or in those causing infection in vivo. In one instance described thus far, the mRNA for a T. cruzi membrane protein of Mr 85,000 was shown to be specifically expressed in trypomastigotes (25) . We have identified several T. cruzi genomic DNA clones in a Xgtll expression library using the antineuraminidase antibodies. The isolation of specific probes, such as the neuraminidase gene, the purified enzyme, and the antineuraminidase antibodies, will allow studies of the enzyme's regulation during the life cycle of T. cruzi and help to elucidate the role it plays in pathogenesis.
